Leon Cooperman - Omega Advisors
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2011 Q3 | 0 | 0.00 | Sell 100.00% | 4.05 | SEC | ||
| 2011 Q2 | 3,362,444 | 4.05 | Add 48.92% | 1.33 | $48.22 | $162,137,000 | SEC |
| 2011 Q1 | 2,257,864 | 2.88 | Add 5.57% | 0.15 | $50.17 | $113,277,000 | SEC |
| 2010 Q4 | 2,138,664 | 2.92 | Reduce 0.21% | <0.01 | $52.13 | $111,489,000 | SEC |
| 2010 Q3 | 2,143,264 | 3.66 | Add 56.16% | 1.32 | $52.75 | $113,057,000 | SEC |
| 2010 Q2 | 1,372,464 | 2.84 | Reduce 15.12% | 0.46 | $51.99 | $71,354,000 | SEC |
| 2010 Q1 | 1,616,864 | 3.01 | Add 7.16% | 0.20 | $63.08 | $101,992,000 | SEC |
| 2009 Q4 | 1,508,764 | 4.51 | Add 1.55% | 0.07 | $56.18 | $84,762,000 | SEC |
| 2009 Q3 | 1,485,764 | 3.13 | Add 1.58% | 0.05 | $50.56 | $75,120,000 | SEC |
| 2009 Q2 | 1,462,664 | 3.88 | Add 9.05% | 0.32 | $49.34 | $72,168,000 | SEC |
| 2009 Q1 | 1,341,264 | 6.46 | Reduce 9.60% | 0.59 | $45.05 | $60,424,000 | SEC |
| 2008 Q4 | 1,483,764 | 6.17 | Add 2.81% | 0.17 | $42.57 | $63,164,000 | SEC |
| 2008 Q3 | 1,443,200 | 3.52 | Reduce 9.59% | 0.24 | $45.79 | $66,084,000 | SEC |
| 2008 Q2 | 1,596,200 | 2.46 | Reduce 10.88% | 0.31 | $45,800.00 | $73,105,960,000 | SEC |
| 2008 Q1 | 1,791,000 | 2.85 | Reduce 15.61% | 0.39 | $46,190.00 | $82,726,290,000 | SEC |
| 2007 Q4 | 2,122,200 | 2.47 | Add 105.74% | 1.27 | $46,480.00 | $98,639,856,000 | SEC |
| 2007 Q3 | 1,031,500 | 1.12 | Reduce 7.54% | 0.08 | $44,470.00 | $45,870,805,000 | SEC |
| 2007 Q2 | 1,115,600 | 1.00 | Add 33.33% | 0.25 | $41,250.00 | $46,018,500,000 | SEC |
| 2007 Q1 | 836,700 | 0.76 | Add 11.12% | 0.08 | $37,430.00 | $31,317,681,000 | SEC |
| 2006 Q4 | 753,000 | 0.65 | Buy | 0.65 | $31.08 | $23,403,000 | SEC |
| 2004 Q4 | 0 | 0.00 | Sell 100.00% | 0.17 | SEC | ||
| 2004 Q3 | 100,000 | 0.17 | Buy | 0.17 | $25.95 | $2,595,000 | SEC |